Do anti-CD25 monoclonal antibodies potentiate posttransplant diabetes mellitus? [electronic resource]
Producer: 20071113Description: 2248-50 p. digitalISSN:- 0041-1345
- Adult
- Antibodies, Monoclonal -- adverse effects
- Antigens, CD -- immunology
- Basiliximab
- Body Mass Index
- Body Weight
- Diabetes Mellitus -- immunology
- Female
- Graft Rejection -- epidemiology
- Humans
- Immunosuppressive Agents -- adverse effects
- Interleukin-2 Receptor alpha Subunit -- immunology
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Postoperative Complications -- immunology
- Recombinant Fusion Proteins -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.